Form 8-K - Current report:
SEC Accession No. 0001193125-22-100473
Filing Date
2022-04-08
Accepted
2022-04-08 17:02:00
Documents
14
Period of Report
2022-04-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d287391d8k.htm   iXBRL 8-K 22940
2 EX-99.1 d287391dex991.htm EX-99.1 8538
6 GRAPHIC g287391g0409010036580.jpg GRAPHIC 3081
  Complete submission text file 0001193125-22-100473.txt   157258

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgen-20220408.xsd EX-101.SCH 2881
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20220408_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20220408_pre.xml EX-101.PRE 10829
8 EXTRACTED XBRL INSTANCE DOCUMENT d287391d8k_htm.xml XML 3203
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 22817743
SIC: 2836 Biological Products, (No Diagnostic Substances)